相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo
Monika Bradl et al.
ANNALS OF NEUROLOGY (2009)
Placebo-Controlled Trial of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Antibody Demyelinating Neuropathy
Marincis C. Dalakas et al.
ANNALS OF NEUROLOGY (2009)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
A review of the current use of rituximab in autoimmune diseases
Hakan M. Guercan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders
H. F. Petereit et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2008)
Response to therapy in myasthenia gravis with anti-MuSK antibodies
Amelia Evoli et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2008)
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
S. Jarius et al.
BRAIN (2008)
Cytokine-producing B lymphocytes - key regulators of immunity
Frances E. Lund
CURRENT OPINION IN IMMUNOLOGY (2008)
Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature
Hiroki Yokoyama et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Successful treatment of cardiac involvement in dermatomyositis with rituximab
Zahi Touma et al.
JOINT BONE SPINE (2008)
Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients
Isabel Illa et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis
Edgar Meinl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura
Luana Benedett et al.
MUSCLE & NERVE (2008)
Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab
Simona Bonavita et al.
NEUROLOGICAL SCIENCES (2008)
LONG-TERM EFFECT OF RITUXIMAB IN ANTI-MAG POLYNEUROPATHY
L. Benedetti et al.
NEUROLOGY (2008)
Invited article: Inhibition of B cell functions - Implications for neurology
Marinos C. Dalakas
NEUROLOGY (2008)
Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: Treatment update
Andreas J. Steck et al.
NEUROTHERAPEUTICS (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rituximab for treatment of opsocionus-myoclonus syndrome in neuroblastoma
Michael J. Burke et al.
PEDIATRIC BLOOD & CANCER (2008)
RESPONSE TO RITUXIMAB AND PREDNISOLONE FOR OPSOCLONUS-MYOCLONUS-ATAXIA SYNDROME IN A CHILD WITH GANGLIONEUROBLASTOMA
Funda Corapcioglu et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2008)
Identification and development of new therapeutics for multiple sclerosis
Ralf A. Linker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
B cells as therapeutic targets in autoimmune neurological disorders
Marinos C. Dalakas
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus
Jessica Bell et al.
PEDIATRIC BLOOD & CANCER (2008)
The potential utility of B cell-directed biologic therapy in autoimmune diseases
D. G. Arkfeld
RHEUMATOLOGY INTERNATIONAL (2008)
Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjogren's syndrome
Pascal Sève et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease
Andrew Chan et al.
JOURNAL OF NEUROLOGY (2007)
Rituximab for the treatment of juvenile dermatomyrositis - A report of four pediatric patients
Megan A. Cooper et al.
ARTHRITIS AND RHEUMATISM (2007)
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M
Luana Benedetti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2007)
A pilot trial of rituximab in the treatment of patients with dermatomyositis
Lorinda Chung et al.
ARCHIVES OF DERMATOLOGY (2007)
Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
Christoph Muench et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
The immunopathology of multiple sclerosis:: An overview
Hans Lassmann et al.
BRAIN PATHOLOGY (2007)
Antigen presentation by B lymphocytes:: how receptor signaling directs membrane trafficking
Fulvia Vascotto et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: A prospective pilot trial
Kenneth C. Gorson et al.
MUSCLE & NERVE (2007)
Rituximab for the treatment of the skin manifestations of dermatomyositis: A report of 3 cases
Hope V. Dinh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
The pathology of MS - New insights and potential clinical applications
Sean J. Pittock et al.
NEUROLOGIST (2007)
Astrocytes are active players in cerebral innate immunity
Cinthia Farina et al.
TRENDS IN IMMUNOLOGY (2007)
A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis
M. Thangarajh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
BCR ubiquitination controls BCR-mediated antigen processing and presentation
Lisa Drake et al.
BLOOD (2006)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target
Marinos C. Dalakas
PHARMACOLOGY & THERAPEUTICS (2006)
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myocionus syndrome
Michael R. Pranzatelli et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: Mechanism of anti body-dependent cellular cytotoxicity and impact of human serum
Marie-Laure Lefebvre et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody
Takahisa Gono et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2006)
Secondary progressive multiple sclerosis: current knowledge and future challenges
M Rovaris et al.
LANCET NEUROLOGY (2006)
Successful treatment of musk antibody-positive myasthenia gravis with rituximab
B Hain et al.
MUSCLE & NERVE (2006)
High-dose rituximab and anti-MAG-associated polyneuropathy
S Renaud et al.
NEUROLOGY (2006)
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
E Meinl et al.
ANNALS OF NEUROLOGY (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis
M Thangarajh et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis
O Stüve et al.
ARCHIVES OF NEUROLOGY (2005)
Tolerability and safety of rituximab (MabThera®)
E Kimby
CANCER TREATMENT REVIEWS (2005)
Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
K Takagi et al.
ANNALS OF HEMATOLOGY (2005)
Treatment of stiff person syndrome with rituximab
MR Baker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
An open label study of the effects of rituximab in neuromyelitis optica
BAC Cree et al.
NEUROLOGY (2005)
Treatment of dysimmune neuropathies
E Nobile-Orazio
JOURNAL OF NEUROLOGY (2005)
Defective B cell tolerance checkpoints in systemic lupus erythematosus
S Yurasov et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis
NL Monson et al.
ARCHIVES OF NEUROLOGY (2005)
Rituximab in the treatment of dermatomyositism - An opel-label pilot study
TD Levine
ARTHRITIS AND RHEUMATISM (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Worsening after rituximab treatment in anti-MAG neuropathy
L Broglio et al.
MUSCLE & NERVE (2005)
Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma
A Gajra et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg
SJ Rüegg et al.
NEUROLOGY (2004)
CSFB-cell expansion in opsoclonus-Myoclonus syndrome: A biomarker of disease activity
MR Pranzatelli et al.
MOVEMENT DISORDERS (2004)
From the bench to the bedside: ways to improve rituximab efficacy
G Cartron et al.
BLOOD (2004)
Rituximab-responsive CIDP
C Briani et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Polymyositis and dermatomyositis
MC Dalakas et al.
LANCET (2003)
Complement activation determines the therapeutic activity of rituximab in vivo
N Di Gaetano et al.
JOURNAL OF IMMUNOLOGY (2003)
Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies
S Renaud et al.
MUSCLE & NERVE (2003)
Determinants of human B cell migration across brain endothelial cells
A Alter et al.
JOURNAL OF IMMUNOLOGY (2003)
Treatment of IgM antibody associated polyneuropathies using rituximab
A Pestronk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Successful treatment of refractory myasthenia gravis using rituximab: A pediatric case report
ME Wylam et al.
JOURNAL OF PEDIATRICS (2003)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
Rituximab for myasthenia gravis developing after bone marrow transplant
F Zaja et al.
NEUROLOGY (2000)
分享论文
